Upgrade to SI Premium - Free Trial

Denali Therapeutics (DNLI)

18.03 -0.63 (3.38%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026 October 22, 2026 4:01 PM - StreetInsider Form 144 Denali Therapeutics Inc. Filed by: Chin Peter Scott September 11, 2026 11:35 AM - SEC Filing Denali Therapeutics Inc. (DNLI) PT Raised to $35 at B.Riley August 25, 2026 8:29 AM - StreetInsider Form 4 Denali Therapeutics Inc. For: Aug 12 Filed by: Watts Ryan J. August 14, 2026 4:48 PM - SEC Filing Form 4 Denali Therapeutics Inc. For: Aug 11 Filed by: Schuth Alexander O. August 13, 2026 5:02 PM - SEC Filing Form 144 Denali Therapeutics Inc. Filed by: Schuth Alexander O. August 11, 2026 5:40 PM - SEC Filing Denali Therapeutics Inc. (DNLI) PT Raised to $34 at UBS August 7, 2026 9:58 AM - StreetInsider Denali Therapeutics Inc. (DNLI) Misses Q2 EPS by 4c August 6, 2026 5:41 PM - StreetInsider Form 10-Q Denali Therapeutics Inc. For: Jun 30 August 6, 2026 4:12 PM - SEC Filing Form 8-K Denali Therapeutics Inc. For: Aug 06 August 6, 2026 4:04 PM - SEC Filing Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights August 6, 2026 4:01 PM - StreetInsider Form SCHEDULE 13G/A Denali Therapeutics Inc. Filed by: BAILLIE GIFFORD & CO August 4, 2026 9:11 AM - SEC Filing Form 8-K Denali Therapeutics Inc. For: Jul 27 July 28, 2026 6:03 AM - SEC Filing Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026 July 27, 2026 4:01 PM - StreetInsider Full Article List